RT Journal Article
SR Electronic
T1 Polygenic scores clarify the relationship between mental health and gender diversity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.22.21266696
DO 10.1101/2021.11.22.21266696
A1 Thomas, Taylor R.
A1 Tener, Ashton J.
A1 Pearlman, Amy M.
A1 Imborek, Katherine L.
A1 Yang, Ji Seung
A1 Strang, John F.
A1 Michaelson, Jacob J.
YR 2022
UL http://medrxiv.org/content/early/2022/08/11/2021.11.22.21266696.abstract
AB Gender diverse individuals are at higher risk for mental health problems. What remains unclear is whether this increased risk is attributable to environmental stressors (e.g., minority stress), to innate genetic factors with pleiotropic effects on gender diversity and mental health, or to gene-by-environment interactions. Here, we present a study of N=701 independent adults (58% autistic) who were thoroughly characterized for gender diversity using the Gender Self Report (GSR), a novel assessment for the continuous, multidimensional characterization of gender diversity. We calculated polygenic scores for 20 behavioral traits, and tested them for association with the continuous dimensions of the GSR: Binary Gender Diversity (degree of identification with the gender opposite that implied by sex designated at birth) and Nonbinary Gender Diversity (degree of identification with a gender that is neither man/male nor woman/female). We found no evidence of association between gender diversity and polygenic risk for adult-onset psychiatric conditions (major depression, bipolar disorder, schizophrenia). Strikingly, we instead found that both gender diversity dimensions were positively associated with polygenic scores for cognitive performance (Binary ρ = 0.09, Nonbinary ρ = 0.11, p < 0.05). We also found Binary Gender Diversity to be positively associated with polygenic scores for both autism (ρ = 0.08, p < 0.05) and non-heterosexual sexual behavior (ρ = 0.09, p < 0.05). Further, we found no association between increasing gender diversity and poorer mental health outcomes in a subsample with low genetic risk for these neuropsychiatric conditions. Only in the subsample with high genetic risk for major depression or schizophrenia did we observe a significant relationship between gender diversity and poor mental health outcomes. These findings suggest that minority stress experienced as a gender diverse person may act with particular potency in those who have high genetic risk for neuropsychiatric disorders. In summary, our findings challenge a pathologizing view of gender diversity, identify pleiotropic relationships with adaptive traits such as cognitive performance, and implicate environment (e.g., minority stress) as a key factor interacting with polygenic risk to generate poor mental health outcomes in gender diverse individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institutes of Health (MH105527 and DC014489 to JM) and the National Institute of Mental Health (R01MH100028 to JS), as well as grants from the Simons Foundation (SFARI 516716 to JM), the Clinical and Translational Science Award (KL2TR001877 to JM), the Fahs-Beck Fellow Grant to JS, and the National Institutes of Health Predoctoral training grant (T32GM008629 to TT). This work was supported by the University of Iowa Hawkeye Intellectual and Developmental Disabilities Research Center (Hawk-IDDRC) through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD103556).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of the University of Iowa gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe SPARK genetic data can be obtained at SFARI Base. The SPARK Research Match data will be available to qualified, approved researchers through SFARI Base upon publication of this article. https://base.sfari.org